Routine Use of Fluoroscopic-Guided Femoral Arterial Puncture to Minimise Vascular Complication Rates in CTO Intervention: Multi-centre UK Experience

Heart Lung and Circulation

Volumn 25, Issue 12, 2016, Pages 1203-1209

  Fairley, Sarah L ^a   Lucking, Andrew J ^b   McEntegart, Margaret ^c   Shaukat, Aadil ^b   Smith, David ^d   Chase, Alexander ^d   Hanratty, Colm G ^a   Spratt, James C ^b   Walsh, Simon J ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

^c GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^d MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Chronic total occlusions; Vascular complications

Indexed keywords

HEPARIN;

ANTICOAGULATION; ARTERIOVENOUS FISTULA; ARTERY PUNCTURE; ARTICLE; CHRONIC TOTAL OCCLUSION; CLINICAL EFFECTIVENESS; EPIGASTRIC ARTERY; FALSE ANEURYSM; FLUOROSCOPIC GUIDED FEMORAL ARTERIAL PUNCTURE; FLUOROSCOPY; HEMATOMA; HEMOSTASIS; HUMAN; ISCHEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; OCCLUSION; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; RISK REDUCTION; VASCULAR ACCESS; VASCULAR CLOSURE DEVICE; ADULT; ADVERSE EFFECTS; AFTERCARE; AGED; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FEMALE; FEMORAL ARTERY; MALE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROTOCOL COMPLIANCE; PUNCTURE; SURGERY; UNITED KINGDOM; VERY ELDERLY;

ADULT; AFTERCARE; AGED; AGED, 80 AND OVER; FEMALE; FEMORAL ARTERY; FLUOROSCOPY; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PUNCTURES; RETROSPECTIVE STUDIES; UNITED KINGDOM;

EID: 84976480710     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2016.04.006     Document Type: Article

References (16)

1. [1] Muller, D.W., Samir, K.J., Ellis, S.G., Topol, E.J., Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol. 69 (1992), 63–68.
2. [2] Ndrepepa, G., Neumann, F.-J., Richardt, G., Schulz, S., Tolg, R., Stoyanov, K.M., et al. Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv. 6 (2013), 354–361.
3. [3] Trimarchi, S., Smith De, Share, D., Jani, S.M., O'Donnell, M., McNamara, R., Retroperitoneal haematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry. JACC Cardiovasc Interv. 3 (2010), 845–850.
4. [4] Levine, G.N., Bates, E.R., Blankenship, J.C., Bailey, S.R., Bittl, J.A., Cercek, B., ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 124 (2011), 2574–2609.
5. [5] Doyle, B.J., Ting, H.H., Bell, M.R., Lennon, R.J., Mathew, V., Singh, M., Major femoral bleeding complications after percutaneous coronary intervention: Incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. J Am Coll Cardiol Intv. 1 (2008), 202–209.
6. [6] Stone, G.W., McLaurin, B.T., Cox, D.A., Bertrand, M.E., Linoff, A.M., Moses, J.W., ACUITY Investigators. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 355 (2006), 2203–2216.
7. [7] Briguori, C., Visconti, G., Focaccio, A., Donahue, M., Golia, B., Selvetella, L., Novel Approaches for Preventing or Limiting Events (NAPLES III) Trial: randomised comparison of bivalirudin versus unfractionated heparin in patients at high risk of bleeding undergoing elective coronary stenting through the femoral approach. Rationale and design. Cardiovasc Drugs Ther. 28 (2014), 273–279.
8. [8] Pitta, S.R., Prasad, A., Kumar, G., Lennon, R., Rihal, C.S., Holmes, D.R., Location of Femoral Artery Access and Correlation with Vascular Complications. Catheter Cardiovasc Interv. 78 (2011), 294–299.
9. [9] Schnyder, G., Sawhney, N., Whisenant, B., Tsimikas, S., Turi, Z.G., Common femoral artery anatomy is influenced by demographics and comorbidities: implications for cardiac and peripheral invasive studies. Catheter Cardiovasc Interv. 53 (2001), 289–295.
10. [10] Lee, M.S., Applegate, B., Rao, S.V., Kirtane, A.J., Seto, A., Stone, G.W., Minimizing femoral artery access complications during percutaneous coronary interventions: A comprehensive review. Catheter Cardiovasc Interv. 84 (2014), 62–69.
11. [11] Turi, Z.G., Fluoroscopy guided vascular access: asking the right question, but getting the wrong answer?. Catheter Cardiovasc Interv. 74 (2009), 540–542.
12. [12] Seto, A.H., Abu-Fadel, M.S., Sparling, J.M., Zacharias, S.J., Daly, T.S., Harrison, A.T., Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc Interv. 3 (2010), 751–758.
13. [13] Ahmed, B., Piper, W.D., Malenka, D., VerLee, P., Robb, J., Ryan, T., Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. Circ Cardiovasc Interv. 2 (2009), 423–429.
14. [14] Fitts J, Ver LP, Hofmaster P, Malenka D. Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications. J Interv Cardiol; 21:273–278.
15. [15] Rafie, I.M., Uddin, M.M., Ossei-Geming, N., Anderson, R.A., Kinnaird, T.D., Patients undergoing PCI from the femoral route by default radial operators are at high risk of vascular access-site complications. EuroIntervention. 9 (2014), 1189–1194.
16. [16] Patel, M.R., Jneid, H., Derdeyn, C.P., Klein, L.W., Levine, G.N., Lockstein, R.A., Arteriotomy closure devices for cardiovascular procedures: A scientific statement from the American Heart Association. Circulation. 122 (2010), 1882–1893.